Improvement of diabetic retinopathy with intravitreal Ranibizumab

Diabetes Research and Clinical Practice

Volumn 100, Issue 1, 2013, Pages

  Kernt, Marcus ^a   Cserhati, Sarah ^a   Seidensticker, Florian ^a   Liegl, Raffael ^a   Kampik, Anselm ^a   Neubauer, Aljoscha ^a   Ulbig, Michael W ^a   Reznicek, Lukas ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anti VEGF; Diabetic macular edema; Diabetic retinopathy; ETDRS; Imaging; Optomap; Ranibizumab; Retinopathy level; SLO

Indexed keywords

HEMOGLOBIN A1C; RANIBIZUMAB;

ARTICLE; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINAL THICKNESS; TREATMENT DURATION; TREATMENT RESPONSE; VISUAL ACUITY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84876735620     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.01.006     Document Type: Article

References (8)

1. Zechmeister-Koss I., Huic M. Vascular endothelial growth factor inhibitors (anti-VEGF) in the management of diabetic macular oedema: a systematic review. Br J Ophthalmol 2012, 96(2):167-178.
2. Chun D.W., Heier J.S., Topping T.M., Duker J.S., Bankert J.M. A pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edema. Ophthalmology 2006, 113(10):1706-1712.
3. Nguyen Q.D., Shah S.M., Khwaja A.A., Channa R., Hatef E., Do D.V., et al. Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 2010, 117(11):2146-2151.
4. Silva P.S., Cavallerano J.D., Sun J.K., Noble J., Aiello L.M., Aiello L.P. Nonmydriatic Ultrawide Field Retinal Imaging Compared with Dilated Standard 7-Field 35-mm Photography and Retinal Specialist Examination for Evaluation of Diabetic Retinopathy. Am J Ophthalmol 2012, 154(3):549-559.
5. Kernt M., Pinter F., Hadi I., Hirneiss C., Haritoglou C., Kampik A., et al. Diabetic retinopathy: comparison of the diagnostic features of ultra-widefield scanning laser ophthalmoscopy Optomap with ETDRS 7-field fundus photography. Ophthalmologe 2011, 108(2):117-123.
6. Kernt M.H.I., Pinter F., Seidensticker F., Hirneiss C., Haritoglou C., Kampik A., et al. Assessment of diabetic retinopathy using non mydriatic ultra-wide field scanning-laser ophthalmoscopy (Optomap) compared to ETDRS 7-field stereo photography. Diabetes Care 2012, in press.
7. Nguyen Q.D., Brown D.M., Marcus D.M., Boyer D.S., Patel S., Feiner L., et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012, 119(4):789-801.
8. Neubauer A.S., Kook D., Haritoglou C., Priglinger S.G., Kampik A., Ulbig M.W., et al. Bevacizumab and retinal ischemia. Ophthalmology 2007, 114(11):2096.